Breaking news

Why the UAE Is Becoming A Premier Destination For Medical Tourism

by THEFUTURE.TEAM

With a commitment to enhancing its healthcare offerings, the UAE has positioned itself as a leader in medical tourism, catering to a growing global demand. As countries focus on improving the health of their populations, the UAE stands out for its strategic investments in both healthcare infrastructure and its appeal to medical tourists.

According to Statista, the global medical tourism market was valued at $47 billion in 2024, with projections indicating it could exceed $111 billion by 2029. The UAE is setting the bar high, with innovative initiatives such as specialized portals for health tourists and streamlined entry processes for medical visitors.

Tailored Portals And Seamless Experiences

Abu Dhabi and Dubai have launched dedicated online platforms that streamline the process for medical tourists. These portals offer a range of services, including healthcare provider contact information, appointment bookings, hotel reservations, and local transportation. Dubai Health Authority (DHA) introduced the Dubai Health Experience (DXH) brand in 2016, aimed at making the city a global leader in health tourism. The platform offers a curated selection of top-tier treatments in fields such as dentistry, fertility, ophthalmology, and cosmetic surgery.

Meanwhile, in 2018, Abu Dhabi’s Department of Health (DoH) rolled out its own e-portal, showcasing a network of over 40 healthcare facilities that meet the stringent quality standards of the DoH’s JAWDA program. Visitors can explore nearly 300 treatment packages across specialties ranging from routine check-ups to complex surgeries.

Simplified Access With Specialized Permits

To further attract international patients, the UAE offers specialized entry permits for medical tourists and their companions. These permits, which can be single or multiple entries, are sponsored by medical institutions and processed by relevant authorities in the country. Dubai Healthcare City also introduced a new medical visa in January 2024, allowing treatment centers to apply for permits on behalf of patients for stays of up to six months. This move bolsters Dubai’s reputation as a medical tourism hotspot.

The city welcomed 674,000 medical tourists in 2022, generating $270 million in revenue. Wellness tourism is also booming in the UAE, with visitors spending $5.4 billion in 2022—almost double the amount spent in 2020.

Innovation At The Forefront

The UAE’s innovative spirit continues to propel its rise as a medical tourism hub. In 2024, HealthStay.io, the world’s first AI-powered medical tourism solution, launched in partnership with Dubai Health Experience. This startup, part of the Mohammed Bin Rashid Innovation Fund’s Accelerator Program, uses artificial intelligence to automate the medical tourism journey, including selecting treatments and booking appointments.

“The launch of HealthStay.io is a direct result of the support from DXH and DHA, helping us transform Dubai into a global healthcare tourism leader,” said Ruairi Tubrid, co-founder of HealthStay.io. Fatima Yousif Alnaqbi, MBRIF representative, emphasized the importance of accelerator programs in supporting innovative solutions that elevate the UAE’s standing as a center of excellence in healthcare.

Government Commitment To Healthcare Excellence

The UAE’s rapid growth in medical tourism is rooted in its consistent focus on healthcare improvement. Key strategies such as the Emirates Health Services Innovation Strategy 2023-2026 and the National Strategy for Wellbeing 2031 aim to enhance residents’ quality of life and elevate the nation’s healthcare offerings.

Compared to its Gulf Cooperation Council (GCC) counterparts, the UAE leads in healthcare expenditure growth. Projections from Alpen Capital estimate that healthcare spending will reach $30.7 billion by 2027, reflecting the nation’s ongoing dedication to strengthening its healthcare infrastructure. As a result, the UAE continues to attract international patients seeking top-tier medical services.

LVMH Revenue Rises, But China Weakness Continues To Weigh On Luxury Giant

by THEFUTURE.TEAM

A Softer Quarter Exposes The Limits Of Luxury’s Recovery

LVMH, the world’s largest luxury group and parent of Louis Vuitton, Dior, Celine and Hennessy, reported revenue of €18.5 billion in the three months to the end of September, underscoring both the scale of its business and the pressure building across parts of the luxury market.

The company’s revenue rose 1.2% year on year in the third quarter, following a 0.1% increase in the second quarter and a 5.9% decline in the first. The trajectory points to stabilization, but not yet to a convincing rebound.

Organic Growth Misses Expectations

Organic sales growth, which strips out currency effects and portfolio changes, slowed to 1% in the third quarter from 3% in the previous quarter. That result fell short of market expectations and reinforced concerns that the luxury cycle remains uneven.

For the first nine months of the year, LVMH generated sales of €57.1 billion, with organic growth of 2%.

In its statement, the company highlighted the breadth of its portfolio, saying that diversification continues to provide resilience in an uncertain geopolitical and economic environment. That remains one of LVMH’s defining strengths: when one category weakens, another can help offset the downturn.

China Remains The Key Pressure Point

LVMH said sales performed well in the United States, Europe and Japan, but conditions in China remained less favorable. That matters because the country has long been one of the most important growth engines for global luxury brands.

The fashion and leather goods division, LVMH’s most closely watched unit, saw organic sales fall 5% as weaker demand in China weighed on performance. Deutsche Bank said the decline was steeper than the roughly 2% drop expected by analysts.

The segment had delivered its first organic sales gain in two years in the previous quarter, making the latest retreat a notable setback.

Brand Equity Faces A Test In China

The quarter also highlighted the reputational risks facing global brands in China. Louis Vuitton drew criticism after suing local tea company Molly Tea over logo copying. Although the company won the case, the dispute sparked social media backlash and boycott calls, adding another layer of pressure to an already fragile environment.

For a company built on scarcity, aspiration and brand discipline, perception is an asset as valuable as inventory. In a market as digitally connected as China, that asset can shift quickly.

Mixed Performance Across The Portfolio

Not every division weakened. LVMH’s selective retailing business, which includes Sephora, posted an 8% organic sales increase. Watches and jewellery, along with wines and spirits, both recorded 6% organic gains.

That broad mix is precisely what has historically given LVMH an advantage over rivals: it can absorb softness in one category without relying on a single growth driver.

Analysts See A Longer Recovery Ahead

Deutsche Bank analysts said the results could lead to further cuts in earnings forecasts for the second half of 2026 and 2027. They added that it is difficult to see what could improve investor sentiment in the near term.

Still, the bank framed the weakness as cyclical rather than structural. In its view, recovery is taking longer because Chinese demand remains subdued, but the problem does not appear to reflect a permanent deterioration in the brand franchise. Analysts said ongoing brand initiatives are beginning to show results, though improvements are likely to remain gradual.

Investor Pressure Continues To Mount

LVMH’s share price has fallen nearly 40% since the start of the year. In September, L’Oréal overtook the group as France’s most valuable listed company, a symbolic shift that captures how sharply sentiment has changed.

Shares in LVMH were down more than 1.6% in Paris around 10 a.m. CEST following the release.

The Future Forbes Realty Global Properties
eCredo
Uol
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter